Evaluation of polyanionic cyclodextrins as high affinity binding scaffolds for fentanyl

Brian P Mayer1,2,3, Daniel J Kennedy1,2,3, Edmond Y Lau1,2,4

  • 1Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, CA, 94550, USA.

Scientific Reports
|February 15, 2023
PubMed
Summary

New cyclodextrins (CDs) show greatly enhanced binding affinity for fentanyl, a synthetic opioid. This breakthrough offers potential for medical countermeasures, biosensors, and forensic applications.